Kenvue Inc (KVUE) Announces Proposed IPO

Kenvue Inc (NYSE: KVUE) has filed for a proposed IPO.

The company describes itself as: "We are the world’s largest pure-play consumer health company by revenue with $15.1 billion in net sales in 2021. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Our differentiated portfolio of iconic brands—including Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec and Nicorette—is built for moments that uniquely matter to our consumers and, we believe, drives positive health outcomes around the world."

Goldman Sachs & Co. LLC and J.P. Morgan will serve as underwriter.

You May Also Be Interested In

• Holtec Nuclear Corporation files for initial public offering
• Nu Mexico gets banking license from Mexico's CNBV
• Niagen Bioscience files to sell up to $50M in common stock